BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 37315641)

  • 1. Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine.
    Challal S; Skiba A; Langlois M; Esguerra CV; Wolfender JL; Crawford AD; Skalicka-Woźniak K
    J Ethnopharmacol; 2023 Dec; 317():116740. PubMed ID: 37315641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal plants for epileptic seizures: Phytoconstituents, pharmacology and mechanisms revisited.
    He X; Chen X; Yang Y; Xie Y; Liu Y
    J Ethnopharmacol; 2024 Feb; 320():117386. PubMed ID: 37956914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential anti-epileptic phytoconstituents: An updated review.
    Kaur J; Famta P; Famta M; Mehta M; Satija S; Sharma N; Vyas M; Khatik GL; Chellappan DK; Dua K; Khurana N
    J Ethnopharmacol; 2021 Mar; 268():113565. PubMed ID: 33166627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy.
    Golub V; Ramakrishnan S; Reddy DS
    Exp Neurol; 2023 Feb; 360():114294. PubMed ID: 36493860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
    Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
    Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herbal medicine for epilepsy seizures in Asia, Africa and Latin America: A systematic review.
    Auditeau E; Chassagne F; Bourdy G; Bounlu M; Jost J; Luna J; Ratsimbazafy V; Preux PM; Boumediene F
    J Ethnopharmacol; 2019 Apr; 234():119-153. PubMed ID: 30610931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery.
    Del Pozo A; Barker-Haliski M
    Exp Neurol; 2023 Feb; 360():114288. PubMed ID: 36471511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy.
    Pietrafusa N; Ferretti A; Trivisano M; de Palma L; Calabrese C; Carfì Pavia G; Tondo I; Cappelletti S; Vigevano F; Specchio N
    Paediatr Drugs; 2019 Aug; 21(4):283-290. PubMed ID: 31179531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V; Reddy DS
    Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
    Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
    CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N; Pietrafusa N; Cross HJ
    Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights.
    Lazarini-Lopes W; Do Val-da Silva RA; da Silva-Júnior RMP; Leite JP; Garcia-Cairasco N
    Neurosci Biobehav Rev; 2020 Apr; 111():166-182. PubMed ID: 31954723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-seizure activity of African medicinal plants: The identification of bioactive alkaloids from the stem bark of Rauvolfia caffra using an in vivo zebrafish model.
    Chipiti T; Viljoen AM; Cordero-Maldonado ML; Veale CGL; Van Heerden FR; Sandasi M; Chen W; Crawford AD; Enslin GM
    J Ethnopharmacol; 2021 Oct; 279():114282. PubMed ID: 34118342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.